scholarly journals Typhoid Fever at the Massachusetts General Hospital during the Past Seventy-Eight Years; Mortality; Intestinal Hemorrhage; Perforation; Relapse

1899 ◽  
Vol 141 (21) ◽  
pp. 509-513
Author(s):  
REGINALD H. FITZ.
Keyword(s):  
Typhoid Fever ◽  
General Hospital ◽  
Massachusetts General Hospital ◽  
The Past ◽  
Intestinal Hemorrhage

scholarly journals Chemotherapy Errors: A Call for a Standardized Approach to Measurement and Reporting

2016 ◽  
Vol 12 (4) ◽  
pp. e495-e501 ◽  
Author(s):  
Inga T. Lennes ◽  
Nie Bohlen ◽  
Elyse R. Park ◽  
Elizabeth Mort ◽  
Debra Burke ◽  
...  
Keyword(s):  
General Hospital ◽  
Massachusetts General Hospital ◽  
Safety Monitoring ◽  
Cancer Center ◽  
Oncology Nursing ◽  
Event Reporting ◽  
Safety Reporting ◽  
The Past ◽  
Chemotherapy Administration ◽  
Safety Event

The Massachusetts General Hospital (MGH) Cancer Center is a multidisciplinary cancer center that delivers chemotherapy to 150 to 200 patients daily and adheres to the Oncology Nursing Society and ASCO guidelines for safe chemotherapy administration. An error that occurred at MGH in the summer of 2012 prompted a review of all safety events, the process of classification, and the monitoring of safety events. This article reviews safety monitoring in the oncology setting, details the oncology safety-event reporting program at MGH, summarizes all chemotherapy-related safety events that have occurred over the past 5 years, and concludes with summary recommendations and potential steps to standardize safety reporting and analysis in chemotherapy administration.

The Evolution of Early Appendectomy as Standard Treatment from Appendicitis: What We Can Learn from the past in Adopting New Medical Therapies

2015 ◽  
Vol 81 (2) ◽  
pp. 161-165 ◽  
Author(s):  
William S. Richardson
Keyword(s):  
General Hospital ◽  
Standard Treatment ◽  
Massachusetts General Hospital ◽  
Vermiform Appendix ◽  
Medical Technologies ◽  
The Past ◽  
Medical Therapies ◽  
Historical Article

Dr. Reginald Fitz popularized early appendectomy for the treatment of appendicitis with his treatise, “Perforating Inflammation of the Vermiform Appendix,” published in 1886 while he worked at the Massachusetts General Hospital along with Dr. Maurice Howe Richardson, the inventor of the Richardson retractor. Their collaboration over the ensuing years led to improvement in outcomes for patients with appendicitis. This historical article describes the importance of this collaboration with information from operative reports, letters, and manuscripts and echoes the discussion today of safely adopting new medical technologies.

Heat-Etching with a Bullivant Type II Simple Freeze-Cleave Device

1970 ◽  
Vol 28 ◽  
pp. 106-107 ◽  
Author(s):  
Ronald S. Weinstein ◽  
N. Scott McNutt
Keyword(s):  
New Zealand ◽  
General Hospital ◽  
Massachusetts General Hospital ◽  
Type I ◽  
Type Ii ◽  
Collaborative Effort ◽  
Temperature And Pressure ◽  
The University

The Type I simple cold block device was described by Bullivant and Ames in 1966 and represented the product of the first successful effort to simplify the equipment required to do sophisticated freeze-cleave techniques. Bullivant, Weinstein and Someda described the Type II device which is a modification of the Type I device and was developed as a collaborative effort at the Massachusetts General Hospital and the University of Auckland, New Zealand. The modifications reduced specimen contamination and provided controlled specimen warming for heat-etching of fracture faces. We have now tested the Mass. General Hospital version of the Type II device (called the “Type II-MGH device”) on a wide variety of biological specimens and have established temperature and pressure curves for routine heat-etching with the device.

Risk Factor Of Substitution ARV First Line People Living With HIV/AIDS In General Hospital Buleleng Bali

2020 ◽  
Vol 9 (1) ◽  
pp. 190-197
Author(s):  
Luh Putu Desy Puspaningrat ◽  
Gusti Putu Candra ◽  
Putu Dian Prima Kusuma Dewi ◽  
I Made Sundayana ◽  
Indrie Lutfiana
Keyword(s):  
Risk Factor ◽  
General Hospital ◽  
Medical Records ◽  
Secondary Data ◽  
District General Hospital ◽  
People Living With Hiv ◽  
First Line ◽  
The Past ◽  
Factor Substitution ◽  
Living With Hiv

Substitution is still a threat to the failure of ARV therapy so that no matter how small it must be noted and monitored in ARV therapy. The aims  was analysis risk factor substitution ARV first line in therapy ARV. This study was an analytic longitudinal study with retrospective secondary data analysis in a cohort of patients receiving ARV therapy at the District General Hospital of Buleleng District for the period of 2006-2015 and secondary data from medical records of PLHA patients receiving ART.  Result in this study that the percentage of first-line ARV substitution events is 9.88% (119/1204) who received ARV therapy for the past 11 years. Risk factors that increase the risk of substitution in ARV therapy patients are zidovudine (aOR 4.29 CI 1.31 -2.65 p 0.01), nevirapine (aOR1.86 CI 2.15 - 8.59 p 0.01) and functional working status (aOR 1.46 CI 1.13 - 1.98 p 0.01). 

Sign in / Sign up

Export Citation Format

Share Document